Externally-Led Patient-Focused Drug Development Meeting on Cystic Fibrosis
CFRI was honored to host an Externally-Led Patient-Focused Drug Development Meeting on Cystic Fibrosis with the FDA on October 29, 2018. During this interactive meeting of individuals with CF, parents/caregivers, clinicians, and FDA representatives, the patient voice was brought to those involved in the drug development and review process.
Over 360 people participated via live-stream; emails and phone calls from across the nation broadened the discussion.
The meeting is available for viewing here: https://www.youtube.com/watch?v=9EBhbzyvP1Q
Silver Sponsor: Proteostasis Therapeutics, Genentech, Ionis Pharmaceuticals, Synspira
Bronze Sponsors: Santhera Pharmaceuticals, Translate Bio, Eloxx Pharmaceuticals, Mylan Pharmaceuticals (through an independent medical education grant), and AzurRx BioPharma.
Watch Our Many Voices ~ One Voice CF Awareness Video!
CFRI’s Many Voices ~ One Voice CF Advocacy and Awareness video features members of our CF community, shares facts about cystic fibrosis, and seeks to inspire you to join CFRI’s advocacy campaign.
Make a difference right away.
Share the video with your friends, family and colleagues.
To watch and share on YouTube, click here.
Cystic Fibrosis Awareness Month: May 2019
Please join us in May 2020!
CFRI’s Sacramento CA Advocacy Day
On May 7, 2019, CFRI advocates spent the day in California’s Capitol meeting with State Assembly Members and Senators to raise awareness of CF and seek support for access to affordable quality care and therapies. Senator Bill Monning sponsored a resolution declaring May as Cystic Fibrosis Awareness Month in the state of California.